Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/5/24 → 12/31/24 |
Funding
- Reversal Therapeutics Incorporated: $34,187.00
Exploiting Emerging Supramolecules as In Vivo Sequestrants to Induce Drug Reversal
- Prisinzano, Thomas (PI)
- Alilain, Warren (CoI)
- Bardo, Michael (CoI)